生物标志物 生物标志物
Ryan T Muir1,2, Andrew E Beaudin3, Cheryl R McCreary3,4
1University of Toronto, Toronto, ON, Canada.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
血神经纤维光链 (NfL) 和较低的粉样β 42/40 (Aβ42/40) 水平与脑粉样血管病变 (CAA) 的认知衰退和大脑变化有关. 这些发现表明白质损伤,而不是tau损伤,驱动CAA患者的认知障碍.
科学领域:
- 神经学 神经学
- 生物标志物研究 生物标志物研究
- 神经成像是一种神经成像.
背景情况:
- 大脑粉样血管病变 (CAA) 是一种与认知障碍相关的脑血管疾病.
- 血生物标志物可以提供关于CAA病理生理学及其对认知的影响的见解.
- 这项研究研究了血生物标志物和CAA中神经成像发现之间的关系.
研究的目的:
- 检查血生物标志物 (Aβ42/40,p-tau,NfL,GFAP) 与CAA患者的认知功能之间的关联.
- 探索这些血生物标记物和神经成像标记物 (例如,白质超强度,皮质体积,脑血管反应) 在CAA中的关系.
- 为了确定CAA中的认知障碍是否与白质损伤或tau相关的皮质损伤有关.
主要方法:
- 一项前性队列研究的横截面分析,涉及可能患有CAA的参与者.
- 血样本进行了Aβ42/40 (Simoa和IP-MS),p-tau181,NfL和GFAP (Simoa) 的分析.
- 参与者接受了磁共振成像 (MRI) 和认知评估,包括蒙特利尔认知评估 (MoCA).
主要成果:
- 较高的NfL水平与较低的MoCA分数和降低的全球脑血管反应率相关.
- 较低的Aβ42/40水平与更慢的处理速度和更高的白质超强度 (WMH) 量有关.
- 更高的GFAP水平与较低的皮质总体积有关,而更高的p-tau181与WMH体积增加有关.
结论:
- 血NfL和降低的Aβ42/40与CAA中的认知缺陷和神经成像异常有关.
- 这些发现表明,CAA中的认知障碍可能源于渐进的白质损伤.
- 这些生物标志物可能有助于阐明大脑粉样血管病变的认知衰退背后的机制.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516